Cargando…
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
It is unclear whether non-alcoholic fatty liver disease (NAFLD) is an independent risk factor for cardiovascular disease. We examined the independent impact of NAFLD on the progression of the coronary artery calcification (CAC) score, a well-known marker of atherosclerosis progression. We examined 1...
Autores principales: | Cho, Yun Kyung, Kang, Yu Mi, Yoo, Jee Hee, Lee, Jiwoo, Lee, Seung Eun, Yang, Dong Hyun, Kang, Joon-Won, Park, Joong-Yeol, Jung, Chang Hee, Kim, Hong-Kyu, Lee, Woo Je |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089954/ https://www.ncbi.nlm.nih.gov/pubmed/30104707 http://dx.doi.org/10.1038/s41598-018-30465-y |
Ejemplares similares
-
Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease
por: Lee, Jiwoo, et al.
Publicado: (2020) -
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
por: Kang, Yu Mi, et al.
Publicado: (2017) -
2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
por: Cho, Yun Kyung, et al.
Publicado: (2016) -
Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
por: Cho, Yun Kyung, et al.
Publicado: (2019) -
Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
por: Yoo, Jee Hee, et al.
Publicado: (2019)